Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Motos

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Expert Opinion on Pharmacotherapy|May 17, 2019
Perspectives on synthetic pharmacotherapy for the treatment of nosocomial pneumoniaAna Motos, Hua Yang, Minlan Yang, et al.
Medizinische Klinik, Intensivmedizin Und Notfallmedizin|December 5, 2023
Corticosteroids in sepsis and community-acquired pneumoniaAmedeo Guzzardella, Ana Motos, Jordi Vallverdú, et al.
Clinics in Chest Medicine|November 5, 2018
Optimizing Antibiotic Administration for PneumoniaAna Motos, James M Kidd, David P Nicolau
European Respiratory Review : an Official Journal of the European Respiratory Society|January 8, 2025
Safety of steroids in severe community-acquired pneumoniaFederica Viola Piedepalumbo, Ana Motos, Francesco Blasi, et al.
Expert Review of Respiratory Medicine|August 16, 2019
Optimal approaches to preventing severe community-acquired pneumoniaGiacomo Tanzella, Ana Motos, Denise Battaglini, et al.
Antimicrobial Agents and Chemotherapy|December 5, 2018
Is One Sample Enough? β-Lactam Target Attainment and Penetration into Epithelial Lining Fluid Based on Multiple Bronchoalveolar Lavage Sampling Time Points in a Swine Pneumonia ModelAna Motos, Joseph L Kuti, Gianluigi Li Bassi, et al.
Antimicrobial Agents and Chemotherapy|January 24, 2019
Efficacy of Human-Simulated Epithelial Lining Fluid Exposure of Meropenem-Nacubactam Combination against Class A Serine β-Lactamase-Producing <i>Enterobacteriaceae</i> in the Neutropenic Murine Lung Infection ModelTomefa E Asempa, Ana Motos, Kamilia Abdelraouf, et al.
International Journal of Antimicrobial Agents|November 10, 2019
Meropenem-nacubactam activity against AmpC-overproducing and KPC-expressing Pseudomonas aeruginosa in a neutropenic murine lung infection modelTomefa E Asempa, Ana Motos, Kamilia Abdelraouf, et al.
International Journal of Antimicrobial Agents|March 19, 2019
Where should antibiotic gradient diffusion strips be crossed to assess synergy? A comparison of the standard method with a novel method using steady-state antimicrobial concentrationsAna Motos, Lindsay M Avery, Kailynn J DeRonde, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 22, 2020
Diagnostic accuracy of Gram staining when predicting staphylococcal hospital-acquired pneumonia and ventilator-associated pneumonia: a systematic review and meta-analysisOtavio T Ranzani, Ana Motos, Chiara Chiurazzi, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Expert Opinion on Pharmacotherapy|May 17, 2019
Perspectives on synthetic pharmacotherapy for the treatment of nosocomial pneumoniaAna Motos, Hua Yang, Minlan Yang, et al.
Medizinische Klinik, Intensivmedizin Und Notfallmedizin|December 5, 2023
Corticosteroids in sepsis and community-acquired pneumoniaAmedeo Guzzardella, Ana Motos, Jordi Vallverdú, et al.
Clinics in Chest Medicine|November 5, 2018
Optimizing Antibiotic Administration for PneumoniaAna Motos, James M Kidd, David P Nicolau
European Respiratory Review : an Official Journal of the European Respiratory Society|January 8, 2025
Safety of steroids in severe community-acquired pneumoniaFederica Viola Piedepalumbo, Ana Motos, Francesco Blasi, et al.
Expert Review of Respiratory Medicine|August 16, 2019
Optimal approaches to preventing severe community-acquired pneumoniaGiacomo Tanzella, Ana Motos, Denise Battaglini, et al.
Antimicrobial Agents and Chemotherapy|December 5, 2018
Is One Sample Enough? β-Lactam Target Attainment and Penetration into Epithelial Lining Fluid Based on Multiple Bronchoalveolar Lavage Sampling Time Points in a Swine Pneumonia ModelAna Motos, Joseph L Kuti, Gianluigi Li Bassi, et al.
Antimicrobial Agents and Chemotherapy|January 24, 2019
Efficacy of Human-Simulated Epithelial Lining Fluid Exposure of Meropenem-Nacubactam Combination against Class A Serine β-Lactamase-Producing <i>Enterobacteriaceae</i> in the Neutropenic Murine Lung Infection ModelTomefa E Asempa, Ana Motos, Kamilia Abdelraouf, et al.
International Journal of Antimicrobial Agents|November 10, 2019
Meropenem-nacubactam activity against AmpC-overproducing and KPC-expressing Pseudomonas aeruginosa in a neutropenic murine lung infection modelTomefa E Asempa, Ana Motos, Kamilia Abdelraouf, et al.
International Journal of Antimicrobial Agents|March 19, 2019
Where should antibiotic gradient diffusion strips be crossed to assess synergy? A comparison of the standard method with a novel method using steady-state antimicrobial concentrationsAna Motos, Lindsay M Avery, Kailynn J DeRonde, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 22, 2020
Diagnostic accuracy of Gram staining when predicting staphylococcal hospital-acquired pneumonia and ventilator-associated pneumonia: a systematic review and meta-analysisOtavio T Ranzani, Ana Motos, Chiara Chiurazzi, et al.
Pageof 5